SOPHiA GENETICS (SOPH) Raw Materials (2020 - 2021)
SOPHiA GENETICS recorded quarterly Raw Materials of $5.1 million in Q4 2021, up 57.17% quarter-over-quarter from $3.2 million in Q4 2020, and up 57.17% year-over-year from $3.2 million in Q4 2020.
SOPHiA GENETICS's Raw Materials history runs 2 years deep, the most recent figure standing at $5.1 million for Q4 2021.
- In Q4 2021, Raw Materials rose 57.17% year-over-year to $5.1 million; the TTM figure through Dec 2021 stood at $5.1 million (up 57.17% YoY), while the FY2021 annual figure was $5.1 million, up 57.17% from the prior year.
- Raw Materials came in at $5.1 million for Q4 2021 at SOPHiA GENETICS, up from $3.2 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $5.1 million in Q4 2021 to a low of $3.2 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | SOPHiA GENETICS | 24.12 Mn | -46.17 Mn | 14.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5.11 Mn |
| Dec 31, 2020 | 3.25 Mn |